Carisma Therapeutics
(OTC) CARM
Carisma Therapeutics Financials at a Glance
Market Cap
$1.50M
Revenue (TTM)
$52.63M
Net Income (TTM)
$8.04M
EPS (TTM)
$0.19
P/E Ratio
0.19
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$0.04
Volume
65,509
Open
$0.04
Price
$0.04
Volume
65,509
Open
$0.04
Previous Close
$0.04
Daily Range
$0.03 - $0.04
52-Week Range
$0.03 - $1.27
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$0.04
Volume
65,509
Open
$0.04
Previous Close
$0.04
Daily Range
$0.03 - $0.04
52-Week Range
$0.03 - $1.27
CARM News
CARM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Carisma Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
46
CEO
Steven Kelly, MBA
Website
www.carismatx.comHeadquarters
Philadelphia, PA 19104, US
CARM Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
21%
Net Income Margin
15%
Return on Equity
0%
Return on Capital
-42%
Return on Assets
1%
Earnings Yield
5.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.50M
Shares Outstanding
41.85M
Volume
65.51K
Short Interest
0.00%
Avg. Volume
136.85K
Financials (TTM)
Gross Profit
$40.04M
Operating Income
$62.18M
EBITDA
$56.83M
Operating Cash Flow
$59.92M
Capital Expenditure
$123.00K
Free Cash Flow
$60.04M
Cash & ST Invst.
$18.83M
Total Debt
$2.48M
Carisma Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$45.25M
+1236.8%
Gross Profit
$45.25M
+1236.8%
Gross Margin
100.00%
N/A
Market Cap
$1.50M
N/A
Market Cap/Employee
$32.70K
N/A
Employees
46
N/A
Net Income
$44.72M
+452.0%
EBITDA
$44.72M
+460.4%
Quarterly Fundamentals
Net Cash
$2.02M
-91.4%
Accounts Receivable
$1.64M
N/A
Inventory
$0.00
N/A
Long Term Debt
$609.00K
-28.9%
Short Term Debt
$153.00K
-93.8%
Return on Assets
1.23%
N/A
Return on Invested Capital
-42.04%
N/A
Free Cash Flow
$1.91M
+114.7%
Operating Cash Flow
$1.91M
+114.7%